6Papi A,Bellettato CM,Braccioni F,et al.Infections and air- way inflammation in chronic obstructive pulmonary disease severe exacerbations[J].Am J Respir Crit Care Med,2006, 173(10) : 1114-1121.
7Marc Miravitlles,Antonio Anzueto.Antibiotics for Acute and Chronic Respiratory Infection in Patients with Chronic Ob- structive Pulmonary Disease[J].Am J Respir Crit Care Med, 2013,188(9) : 1052-1057.
8Miravitlles M.Exacerbations of chronic obstructive pulmonary disease : When are bacterial important [ J ].Eur Respir J, 2002,20(36s) : 9.
9American Thoracic Society.Guidelines for the Six-Minute Walk Test [ J ].Am J Respir Crit Care Med, 2002, 166 ( 1 ) : 111-117.
6Jones PW, Quirk FH, Baveystock CM, et al. A self-complete measure of health status for chronic airflow limitation: The St George's respiratory questionnaire[J]. Am Rev Respir Dis, 1992;145(4):1321-1327.
7Wilkinson TM, Patel IS, Wilks M, et al. Airway bacterial load and FEVt decline in patients with chronic obstructive pulmonary disease [J]. Am J RespirCrit Care Med, 2003, 167 (8): 1090-1095.
9Prieto A, Reyes E. Defective natural killer and phagocytic activities in chronic obstruetive pulmonary disease are restored by glycophopeptieal (immunoferon) [J]. AmJ RepirCritCareMed, 2001, 163 (7): 1578 - 1583.
10Apisarnthanarak A, Pinitchai U, Thongphubeth K, et al. A multifacet- ed intervention to reduce pandrug- resistant col- onization and infeetion in 3 intensive care units in a Thai Tertiary care: A 3 years study [J]. Clin Infect Dis, 2008, 47 (6) : 760 -767.
